Stock listing

CSE:IZO Izotropic Corp. Stock

Home listing (CSE) of Izotropic Corp.

Follow Izotropic Corp. into a list and get an email when it puts out news.

Share price · CSE:IZO

$0.125 CAD +0.020 (+19.0%)

Close on Nov 20, 2026

Past year -62.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.125 – $0.125 CADNov 20, 2026
Volume
6,455 sharesNov 20, 2026
Market cap
$9.04M CADAt the close on Nov 20, 2026 · price × 72.32M shares outstanding
52-week range
$0.100 – $0.360 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$3,668 CADMedian day 9,600 shares · 14 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Izotropic Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
CSE:IZO · Home$0.125 CAD+0.020 (+19.0%)6,455$0.125$0.125$0.125$0.105Close on Nov 20, 2026
OTC:IZOZF$0.084 USD-0.006 (-6.3%)7,244$0.084$0.084$0.084$0.090Close on Nov 20, 2026
Frankfurt:1R3€0.057 EUR+0.002 (+3.7%)—€0.057€0.057€0.057€0.055Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · CSE:IZO · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.125+0.020+19.0%$0.125$0.125$0.1256,455
$0.105-0.020-16.0%$0.105$0.110$0.1054,000
$0.1250.0000.0%$0.125$0.125$0.1250
$0.1250.0000.0%$0.125$0.125$0.1250
$0.1250.0000.0%$0.125$0.125$0.1250
$0.1250.0000.0%$0.125$0.125$0.12523,787
$0.1250.0000.0%$0.125$0.125$0.1250
$0.1250.0000.0%$0.125$0.125$0.1250
$0.1250.0000.0%$0.125$0.125$0.12021,070
$0.125+0.010+8.7%$0.125$0.125$0.1253,566
$0.115+0.015+15.0%$0.125$0.135$0.1158,485
$0.100-0.010-9.1%$0.110$0.125$0.10096,652
$0.110-0.025-18.5%$0.130$0.140$0.100164,050
$0.1350.0000.0%$0.135$0.135$0.13522,000
$0.135-0.005-3.6%$0.140$0.140$0.13511,014
$0.1400.0000.0%$0.140$0.140$0.1400
$0.140-0.005-3.4%$0.150$0.150$0.1406,000
$0.1450.0000.0%$0.145$0.145$0.1450
$0.145+0.005+3.6%$0.145$0.145$0.1454,530
$0.1400.0000.0%$0.140$0.140$0.1400
$0.140-0.020-12.5%$0.145$0.145$0.14022,000
$0.160+0.005+3.2%$0.155$0.160$0.15538,920
$0.1550.0000.0%$0.155$0.155$0.15034,000
$0.155+0.005+3.3%$0.160$0.160$0.150103,501
$0.1500.0000.0%$0.150$0.150$0.1500
$0.150-0.010-6.3%$0.160$0.160$0.15044,500
$0.1600.0000.0%$0.150$0.160$0.15026,490
$0.160-0.020-11.1%$0.165$0.165$0.15063,096
$0.180+0.010+5.9%$0.180$0.180$0.18010,000
$0.170+0.030+21.4%$0.170$0.170$0.1701,971
$0.140-0.040-22.2%$0.165$0.165$0.14065,200
$0.180+0.015+9.1%$0.175$0.180$0.17511,000
$0.165-0.005-2.9%$0.190$0.190$0.16518,000
$0.170-0.025-12.8%$0.190$0.190$0.1709,600
$0.1950.0000.0%$0.195$0.195$0.1950
$0.195-0.005-2.5%$0.195$0.195$0.19064,000
$0.200+0.005+2.6%$0.200$0.205$0.19569,000
$0.195-0.005-2.5%$0.200$0.200$0.1956,800
$0.200+0.010+5.3%$0.195$0.205$0.19517,750
$0.190-0.010-5.0%$0.280$0.280$0.175129,086
$0.200-0.010-4.8%$0.225$0.225$0.2002,501
$0.210+0.020+10.5%$0.210$0.210$0.210800
$0.1900.0000.0%$0.190$0.190$0.1900
$0.190-0.035-15.6%$0.200$0.215$0.19026,349
$0.225+0.035+18.4%$0.225$0.225$0.2255,000
$0.190-0.010-5.0%$0.190$0.190$0.1907,505
$0.200-0.010-4.8%$0.190$0.210$0.19027,595
$0.2100.0000.0%$0.210$0.210$0.19034,360
$0.210-0.005-2.3%$0.210$0.210$0.2101,250
$0.2150.0000.0%$0.225$0.225$0.21514,887
$0.215-0.005-2.3%$0.225$0.225$0.21524,500
$0.220-0.015-6.4%$0.220$0.225$0.21526,972
$0.2350.0000.0%$0.235$0.235$0.2350
$0.2350.0000.0%$0.215$0.235$0.21533,000
$0.235+0.020+9.3%$0.215$0.235$0.21515,017
$0.2150.0000.0%$0.235$0.235$0.2155,704
$0.215-0.020-8.5%$0.225$0.225$0.21511,650
$0.235-0.005-2.1%$0.235$0.235$0.23051,150
$0.2400.0000.0%$0.240$0.240$0.2400
$0.240+0.010+4.3%$0.230$0.240$0.23017,750
$0.2300.0000.0%$0.235$0.235$0.2309,000
$0.230-0.005-2.1%$0.220$0.230$0.2204,500
$0.235-0.010-4.1%$0.235$0.235$0.2352,000
$0.2450.0000.0%$0.245$0.245$0.2450
$0.2450.0000.0%$0.245$0.245$0.2453,500
Ticker
CSE:IZO
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
CSE
Currency
CAD

What changed lately

Latest news

All Izotropic Corp. news

Izotropic Corp. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
11 in the last 12 months · 38 in all · newest Oct 6, 2026 · oldest 2025
Decks
18 decks · latest 2026

Where Izotropic Corp. is listed

ListingExchangeCountryCurrency
CSE:IZO · Home listing · This pageCSECanadaCAD
OTC:IZOZFOTCUnited StatesUSD
gettex:1R3gettexGermanyEUR
LS Exchange:A2JNLVLS ExchangeGermanyEUR
Lang & Schwarz:A2JNLVLang & SchwarzGermanyEUR
Tradegate:1R3TradegateGermanyEUR
Frankfurt:1R3FrankfurtGermanyEUR
Munich:1R3MunichGermanyEUR
Cboe Canada:IZOCboe CanadaCanadaCAD
Stuttgart:1R3StuttgartGermanyEUR

Valuation

Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026

Enterprise value
$8.98M CAD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P/TSX Composite
0.21

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Izotropic Corp. · CSE:IZOUS$6.30MUS$6.26Mn/an/an/an/an/an/a0.21
Clinical Laserthermia Systems AB Class B · OMXSTO:CLS_BUS$7.54MUS$7.17Mn/a5.8×n/a1.6×−314.6%0.0×n/a
BioElectronics Corp. · OTC:BIELUS$7.41MUS$23.70Mn/a46.4×n/an/a−104.3%n/a2.45
Airway Medix SA · GPW:AWMUS$6.73MUS$10.07Mn/a278×n/an/an/an/an/a
Surgical Innovations Group plc · LSE:SUNUS$6.71MUS$7.01Mn/a0.5×n/a0.7×−7.7%0.1×n/a
Accuray Incorporated · NASDAQ:ARAYUS$6.20MUS$65.61Mn/a0.2×n/a0.1×−4.4%1.9×2.46
NeuroOne Medical Technologies Corporation · NASDAQ:NMTCUS$5.94MUS$3.89Mn/a0.4×n/a1.6×−78.6%0.0×1.07
Neola Medical AB · OMXSTO:NEOLAUS$5.46MUS$5.07Mn/an/an/a0.6×n/a0.0×n/a
ENDRA Life Sciences Inc. · NASDAQ:NDRAUS$5.36MUS$3.85Mn/an/an/a1.0×n/a0.0×1.07
MEKICS Co., Ltd. · KRX:058110US$5.23MUS$2.04M6.6×0.2×1.3×0.2×7.7%0.1×n/a
PT Hetzer Medical Indonesia Tbk · IDX:MEDSUS$5.16MUS$5.45Mn/an/an/a1.8×n/a0.1×n/a
Median of the othersUS$6.07MUS$6.23M6.6×0.5×1.3×0.9×−43.2%0.0×1.76

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
1.16 CAD · Analysts' mean
Revenue, year to Apr 2027
5M · 1 analyst

Team and board

Officers

OfficerRole
Robert ThastCEO, Director
Ralph ProceviatCPA, CFO, Director
Andrew HernandezPh.D., Head of Imaging Technology
Jaclyn ThastOperations Manager
John BoonePh.D., Principal Founder of Breast CT, Director
Mohammed SairGeneral Manager

Board

DirectorRole
Alexander TokmanDirector
Ali SodagarLegal Advisor, Director
John BoonePh.D., Principal Founder of Breast CT, Director
Ralph ProceviatCPA, CFO, Director
Robert ThastCEO, Director

Decks

DeckKindSlidesDate
Investor Presentation (2026)Investor deck15 slides2026
Investor Presentation (2026)Investor deck12 slides2026
Investor Presentation (August 2025)Investor deck12 slidesAugust 2025
Fact Sheet (August 2025)Fact sheet2 slidesAugust 2025
Investor Presentation (March 2024)Investor deck13 slidesMarch 2024
Fact Sheet (January 2023)Fact sheet2 slidesJanuary 2023
Investor Presentation (December 2022)Investor deck26 slidesDecember 2022
Investor Presentation (September 2022)Investor deck26 slidesSeptember 2022
Investor Presentation (May 2022)Investor deck26 slidesMay 2022
Investor Presentation (April 2022)Investor deck28 slidesApril 2022
All 18 decks
DeckKindSlidesDate
Investor Presentation (December 2021)Investor deck28 slidesDecember 2021
Investor Presentation (October 2021)Investor deck22 slidesOctober 2021
Investor Presentation (April 2021)Investor deck20 slidesApril 2021
Investor Presentation (March 2021)Investor deck20 slidesMar 22, 2021
Fact Sheet (December 2020)Fact sheet1 slideDecember 2020
Fact Sheet (September 2020)Fact sheet1 slideSeptember 2020
Fact Sheet (June 2020)Fact sheet1 slideJune 2020
Investor PresentationInvestor deck11 slides

Open Decks

Financings

RaiseDateIn US dollars
Private placement of units
Closed: C$150,000 raised · C$0.2 a unit · 1 warrant at C$0.3 for 36 months
Use of proceeds: General working capital
Oct 6, 2026US$105,441
Private placement of units
Closed: C$300,000 raised · C$0.25 a unit · 1 warrant at C$0.25 for 36 months
Use of proceeds: General working capital
Feb 4, 2026US$219,491
Private placement of units
Closed: C$375,000 raised · C$0.25 a unit · 1 warrant at C$0.5 for 36 months
Insiders: An insider of the Company acquired 100,000 Units
Use of proceeds: General working capital
Sep 19, 2025US$271,976

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CAD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue0000000000
Cost of revenue33.9K0
Gross profit-33.9K0
Research and development723.2K681.2K795.2K2.39M3.41M793.0K0
Selling, general and administrative540.4K1.35M703.8K2.74M3.16M3.90M1.09M392.0K560.4K79.3K
Operating income-1.44M-2.22M-1.70M-5.33M-6.64M-4.98M-1.16M-398.5K-598.9K-79.3K
Depreciation and amortization33.4K48.9K59.1K30.9K6.87K1.63K3.28K6.54K4.54K4.54K
EBITDA-1.41M-2.17M-1.64M-5.30M-6.63M-4.97M-1.15M-392.0K-594.4K-74.8K
Interest expense478.5K286.1K253.1K294.4K19.5K00000
Income before tax-2.18M-3.14M-1.56M-5.66M-6.65M-4.98M-1.16M-398.5K-730.1K-107.3K
Income tax00
Net income-2.18M-3.14M-1.56M-5.66M-6.65M-4.98M-1.16M-398.5K-730.1K-107.3K
Earnings per share, basic-0.03-0.05-0.03-0.11-0.15-0.12-0.04-0.02

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents219.7K274.1K38.6K165.7K1.86M4.06M613.6K308.5K471.9K149.4K
Receivables13.4K41.3K43.9K47.2K12.3K6.50K247
Current assets330.4K395.7K166.2K317.3K2.25M4.69M774.0K332.5K478.6K149.7K
Property, plant and equipment124.8K19.0K1.63K3.26K6.54K13.1K
Total assets439.8K414.7K232.4K442.1K2.27M4.69M777.2K339.1K491.6K149.7K
Accounts payable2.89M2.45M1.79M1.15M378.0K94.7K61.5K10.2K69.9K15.8K
Current liabilities5.99M5.27M4.06M3.46M2.64M169.3K70.0K22.2K83.9K214.4K
Total liabilities6.06M5.27M4.08M3.52M2.64M169.3K70.0K22.2K83.9K214.4K
Shareholders' equity-5.63M-4.86M-3.85M-3.07M-374.6K4.52M707.2K316.8K407.8K-64.7K
Shares outstanding69.7M64.4M55.0M51.9M44.8M42.0M30.0M23.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-851.3K-636.2K-593.6K-3.27M-4.76M-3.08M-987.4K-442.6K-604.9K-55.2K
Capital spending0-1.14K0-36.2K-24.2K-24.2K-24.2K-24.2K-17.6K-17.6K
Free cash flow-851.3K-637.4K-593.6K-3.30M-4.79M-3.08M-987.4K-442.6K-622.5K-72.8K
Cash from investing-36.2K-24.2K-24.2K-24.2K-24.2K-17.6K-17.6K
Cash from financing793.6K872.8K468.2K1.61M2.58M6.53M1.29M279.2K945.0K218.2K
Dividends paid00000
Change in cash-54.4K235.5K-127.1K-1.69M-2.21M3.45M305.1K-163.4K322.5K163.0K

Open Financials

Cap table

Built by 6ix from Izotropic Corp.’s releases · as of Oct 6, 2026

Common shares
72,324,679
Fully diluted
73,074,679

Fully diluted

LineSharesAs of
Common shares72,324,679Oct 6, 2026
Options and RSUs750,000Aug 10, 2026

Warrants and options

Lot
Warrants · C$0.30 · expire about Oct 2029
Warrants · C$0.25 · expire about Feb 2029
Warrants · C$0.50 · expire about Sep 2028
RSUs · expiry not stated

Share count over time

CountShares
Nov 22, 202672,324,679
Oct 6, 202670,474,679
Jul 31, 202669,724,679

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Nvwm, LLC500<0.01%US$70Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alexander TokmanDirector · Since at least Nov 5, 2026
Ali SodagarLegal Advisor, Director · Since at least Nov 5, 2026
Andrew HernandezPh.D., Head of Imaging Technology · Since at least Nov 5, 2026
Jaclyn ThastOperations Manager · Since at least Nov 5, 2026
John BoonePh.D., Principal Founder of Breast CT, Director · Since at least Mar 25, 2025
John M. ViglottiSVP Corporate Services · Mar 10, 2025 – Nov 4, 2026 · Past
Mohammed SairGeneral Manager · Since at least Apr 29, 2026
Ralph ProceviatCPA, CFO, Director · Since at least Nov 5, 2026
Robert ThastCEO, Director · Since at least Oct 6, 2026

Open People

Log in to ask 6ix AI your own questions about Izotropic Corp.